Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Martin Makary
Biotech
Biotech leaders urge FDA to not restrict abortion pill access
The letter notes that there are "over a hundred peer-reviewed studies" demonstrating mifepristone's safety and efficacy.
Darren Incorvaia
Jul 2, 2025 2:14pm
Fierce Pharma
FDA's acting CDER head heads for the exit: report
Jun 23, 2025 1:48pm
FDA debuts priority review voucher with 2-month timeline goal
Jun 17, 2025 11:59am
At cell and gene roundtable, officials pledge to slash regulations
Jun 5, 2025 2:50pm
FDA launces generative AI tool Elsa a month ahead of schedule
Jun 3, 2025 10:40am
Martin Makary outlines AI plans, broad vision for FDA leadership
May 15, 2025 12:00pm